Barbara Finck

Barbara Finck

Director/Board Member at
Comera Life Sciences, Inc.
79 year
Health Technology
Consumer Services

Profile

Dr. Barbara K.
Finck
, MD, is on the Board of Directors at Comera Life Sciences, Inc. Dr. Finck was previously employed as an Independent Director by Forte Biosciences, Inc., a Chief Medical Officer by Coherus BioSciences, Inc., a Chief Medical Officer & Senior Vice President by NKT Therapeutics, Inc., a Chief Medical Officer & Senior Vice President by Osprey Pharmaceuticals Ltd., a Chief Medical Officer & Senior VP-Research by Osprey Pharmaceuticals USA, Inc., a Vice President-Clinical Development by Protein Design Labs, Inc., a Vice President-Clinical Development by EOS Biotechnology, Inc., a Medical Director by Immunex Corp., a Manager-Clinical Program by ALZA Corp., an Assistant Professor by The University of California, San Francisco, and a Vice President-Clinical Development by PDL BioPharma, Inc. She also served on the board at Comera Life Sciences Holdings, Inc. She received her undergraduate degree from the University of California, Santa Barbara and a doctorate degree from UCSF School of Medicine.

Barbara Finck active positions

CompaniesPositionStart
Director/Board Member 2001-02-28

Former positions of Barbara Finck

CompaniesPositionEnd
FORTE BIOSCIENCES Director/Board Member 2026-08-26
COMERA LIFE SCIENCES HOLDINGS, INC. Director/Board Member 2023-01-02
COHERUS ONCOLOGY, INC. Chief Tech/Sci/R&D Officer 2022-03-14
Chief Tech/Sci/R&D Officer 2012-06-30
Chief Tech/Sci/R&D Officer 2010-05-31
See the detail of Barbara Finck's experience

Training of Barbara Finck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!